Diamond BiofundTPE:6901 -3.43%16 Quick Ratio is 56.91 as of Dec. 2025, which is 4% below its 10-year median of 59.42. GuruFocus rates TPE:6901 with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 706 Asset Management companies, Diamond Biofund ranks better than 90.51% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Diamond Biofund's quick ratio for the quarter that ended in Dec. 2025 was 56.91.
Diamond Biofund has a quick ratio of 56.91. It generally indicates good short-term financial strength.
The historical rank and industry rank for Diamond Biofund's Quick Ratio or its related term are showing as below:
TPE:6901'
s Quick Ratio Range Over the Past 10 Years
Min: 24.76 Med: 59.42 Max: 146.38
Current: 56.91
During the past 7 years, Diamond Biofund's highest Quick Ratio was 146.38. The lowest was 24.76. And the median was 59.42.
TPE:6901's Quick Ratio is ranked better than 90.51% of 706
companies
in the Asset Management industry
Industry Median: 2.795
vs TPE:6901: 56.91
Diamond Biofund (TPE:6901) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Diamond Biofund Quick Ratio Related Terms
Diamond Biofund Quick Ratio Historical Data
* Premium members only.
The historical data trend for Diamond Biofund's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Diamond Biofund's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diamond Biofund Quick Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Diamond Biofund's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Diamond Biofund's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Diamond Biofund's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diamond Biofund (TPE:6901) has a Quick Ratio of 56.91 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Diamond Biofund and its competitors. This is near median its historical median of 59.42. Over the past decade, Diamond Biofund's Quick Ratio has ranged from 24.76 to 146.38. According to the industry distribution chart, Diamond Biofund ranks #67 out of 706 companies in the Asset Management industry, placing it in the top 9.5%.
Is Diamond Biofund's Quick Ratio too high?
Diamond Biofund's current Quick Ratio of 56.91 is near median its 10-year median of 59.42. Over the past 10 years, this metric has ranged from a low of 24.76 to a high of 146.38. The Asset Management industry median Quick Ratio is 2.80. Diamond Biofund's value of 56.91 is 1936.1% above this industry median. Based on the distribution chart, Diamond Biofund ranks #67 out of 706 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Diamond Biofund has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Quick Ratio compare to BLK and BX?
According to the Asset Management industry distribution chart, Diamond Biofund ranks #67 out of 706 companies for Quick Ratio. This places Diamond Biofund in the top 10% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 2.80. Diamond Biofund's value of 56.91 is 1936.1% above this benchmark. Historically, Diamond Biofund's own Quick Ratio has ranged from 24.76 to 146.38 over the past decade. While the company's 10-year median is 59.42 vs. the industry median of 2.80, Diamond Biofund has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for an Asset Management company?
The median Quick Ratio among Asset Management companies is 2.80, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diamond Biofund's current Quick Ratio of 56.91 is 1936.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Diamond Biofund and its competitors. For the Asset Management industry, the median Quick Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diamond Biofund's current Quick Ratio is 56.91, which is near median its own 10-year median of 59.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Quick Ratio of 56.91. The current Quick Ratio is 56.91, which is near median its 10-year median of 59.42 and 1936.1% above the Asset Management industry median of 2.80. Diamond Biofund's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Quick Ratio is 56.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
16GF Score
Get the complete analysis for TPE:6901
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6901 has been successfully added to your 
